Biomerica (BMRA) CEO Zackary S. Irani Buys 31,250 Shares

What Happened Zackary S. Irani, CEO of Biomerica, purchased 31,250 shares of the company's common stock on August 26, 2026. The shares were acquired in a private placement at $1.60 per share for a total purchase price of $50,000. This was a direct purchase (transaction code P), not a sale or option exercise — purchases are often viewed by investors as a more bullish signal than sales.

Key Details

• Transaction date and price: August 26, 2026 — 31,250 shares at $1.60 per share (total $50,000).
• Shares owned after transaction: Not specified in the filing excerpt provided.
• Footnote: The shares were acquired in a private placement under a Securities Purchase Agreement dated August 20, 2026, with certain institutional and individual investors (including B. Riley Principal Capital, LLC and certain board members and executive officers).
• Filing timeliness: Report filed on August 27, 2026 for an August 26 transaction — filed within the Form 4 reporting window (not reported late).

Context This was a private placement with other institutional and insider participants, not an open-market purchase. Private placements can involve negotiated terms and investors beyond the reporting insider. The transaction is straightforward (a direct purchase), not a derivative exercise or gift, and does not by itself explain the insider’s motives.